Pathology evaluation of sentinel lymph nodes in breast cancer: Protocol recommendations and rationale

Modern Pathology

Volumn 23, Issue , 2010, Pages S26-S32

  Weaver, Donald L ^a,b  

^a UNIVERSITY OF VERMONT COLLEGE OF MEDICINE   (United States)

^b FLETCHER ALLEN HEALTH CARE   (United States)

Author keywords

Breast cancer; Evaluation; Micrometastases; Protocols; Sentinel lymph nodes; Standards

Indexed keywords

PARAFFIN;

BREAST CANCER; CANCER CLASSIFICATION; CANCER DIAGNOSIS; CANCER PATIENT; CANCER STAGING; CLINICAL EVALUATION; CLINICAL PROTOCOL; HISTOPATHOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; LYMPH NODE BIOPSY; LYMPH NODE METASTASIS; MICROMETASTASIS; PRIORITY JOURNAL; REVIEW; SENSITIVITY AND SENSIBILITY; SENTINEL LYMPH NODE; TISSUE DISTRIBUTION; TISSUE SECTION; TUMOR VOLUME;

BREAST NEOPLASMS; FEMALE; HISTOCYTOLOGICAL PREPARATION TECHNIQUES; HUMANS; NEOPLASM STAGING; PRACTICE GUIDELINES AS TOPIC; SENTINEL LYMPH NODE BIOPSY;

EID: 77952008161     PISSN: 08933952     EISSN: 15300285     Source Type: Journal    
DOI: 10.1038/modpathol.2010.36     Document Type: Article

References (16)

1. Krag DN, Weaver DL, Alex JC, et al. Surgical resection and radiolocalization of the sentinel lymph node in breast cancer using a gamma probe. Surg Oncol 1993;2:335-340.
2. Weaver DL, Krag DN, Ashikaga T, et al. Pathologic analysis of sentinel and non-sentinel lymph nodes in breast carcinoma: a multicenter study. Cancer 2000;88:1099-1107.
3. Chen SL, Hoehne FM, Giuliano AE. The prognostic significance of micrometastases in breast cancer: a SEER population-based analysis. Ann Surg Oncol 2007;14:3378-3384.
4. Michaelson JS, Silverstein M, Sgroi D, et al. The effect of tumor size and lymph node status on breast carcinoma lethality. Cancer 2003;98:2133-2143.
5. Greene FL, Page DL, Fleming ID, et al. (eds). AJCC Cancer Staging Manual, 6th edn. Springer: New York, 2002.
6. Sobin LH, Wittekind Ch, (eds). UICC TNM Classification of Malignant Tumours, 6th edn. John Wiley and Sons: New York, 2002.
7. Cserni G, Amendoeira I, Apostolikas N, et al. Discrepancies in current practice of pathological evaluation of sentinel lymph nodes in breast cancer. Results of a questionnaire-based survey by the European Working Group for Breast Screening Pathology. J Clin Pathol 2004;57:695-701.
8. Cserni G, Bianchi S, Vezzosi V, et al. Variations in sentinel node isolated tumour cells/micrometastasis and non-sentinel node involvement rates according to different interpretations of the TNM definitions. Eur J Cancer 2008;44:2185-2191.
9. Turner RR, Weaver DL, Cserni G, et al. Nodal stage classification for breast carcinoma: improving interobserver reproducibility through standardized histologic criteria and image-based training. J Clin Oncol 2008;26:258-263.
10. Nemoto T, Vana J, Bedwani RN, et al. Management and survival of female breast cancer: results of a national survey by the American College of Surgeons. Cancer 1980;45:2917-2924.
11. Huvos AG, Hutter RVP, Berg JW. Significance of axillary macrometastases and micrometastases in mammary cancer. Ann Surg 1971;173:44-46.
12. Weaver DL, Le UP, Dupuis SL, et al. Metastasis detection in sentinel lymph nodes: comparison of a limited widely spaced (NSABP protocol B-32) and a comprehensive narrowly spaced paraffin block sectioning strategy. Am J Surg Pathol 2009;33:1583-1589.
13. Krag DN, Julian TB, Harlow SP, et al. NSABP-32: Phase III randomized trial comparing axillary resection with sentinel lymph node dissection: a description of the trial. Ann Surg Oncol 2004;11(3 Suppl):208s-210s.
14. Weaver DL, Krag DN, Manna EA, et al. Detection of occult sentinel lymph node micrometastases by immunohistochemistry in breast cancer: an NSABP protocol B-32 quality assurance study. Cancer 2006;107:661-667.
15. Fitzgibbons PL, Page DL, Weaver D, et al. Prognostic factors in breast cancer. College of American Pathologists consensus statement 1999.Arch Pathol Lab Med 2000;124:966-978.
16. Lyman GH, Giuliano AE, Somerfield MR, et al. American Society of Clinical Oncology Guideline recommendations for sentinel lymph node biopsy in early-stage breast cancer. J Clin Oncol 2005;23: 7703-7720.